Aquestive Therapeutics (NASDAQ:AQST) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aquestive Therapeutics (AQST) operate in?

Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Aquestive Therapeutics Stock (NASDAQ: AQST) stock price, news, charts, stock research, profile.

Open	$4.69
Close	-
Volume / Avg.	134.48K / 1.34M
Day Range	$4.54 - $4.69
52 Wk Range	1.73 - 6.23
Market Cap	$418.96M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	13.32%
Days to Cover	7.29

Recent News

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

Aquestive Therapeutics hosted a virtual investor day, announcing advancements in Anaphylm and AQST-108. The company aims for FDA meetings in late 2024, targeting a 2025 NDA submission, while HC Wainwright raises its price target amid promising developments.

Vandana Singh

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Aquestive Therapeutics released topline pharmacokinetic data for Anaphylm (epinephrine) Sublingual Film for severe allergic reactions.

Vandana Singh

Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.69
Close	-
Volume / Avg.	134.48K / 1.34M
Day Range	$4.54 - $4.69
52 Wk Range	1.73 - 6.23
Market Cap	$418.96M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	13.32%
Days to Cover	7.29

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aquestive Therapeutics (AQST) stock?

You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.

View our list of the best stock brokerages

Who are Aquestive Therapeutics (AQST) competitors?

Other companies in Aquestive Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).

What is the forecast, or price target, for Aquestive Therapeutics (AQST) stock?

Aquestive Therapeutics has a consensus price target of $9.06.

What is the current price for Aquestive Therapeutics (AQST)?

The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4.7001 last updated November 21, 2024 at 9:20 AM EST.

Does Aquestive Therapeutics (AQST) pay a dividend?

There are no upcoming dividends for Aquestive Therapeutics.

When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?

Aquestive Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.

Is Aquestive Therapeutics (AQST) going to split?

There is no upcoming split for Aquestive Therapeutics.

What sector and industry does Aquestive Therapeutics (AQST) operate in?

Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Aquestive Therapeutics

Aquestive Therapeutics (AQST) Forecast